Want to see AU:ANN full AI Analyst Report?
Top Page
Ansell
(Sydney:ANN)
Select Model
Select Model
Rating:72Outperform
Price Target:
AU$46.00
▲(11.22% Upside)
Action:Reiterated
Date:08/26/26
The score is driven primarily by improved financial performance (margin expansion and sharply stronger free cash flow) and a constructive earnings outlook with positive execution and guidance. Technicals are supportive but tempered by an overbought RSI, and valuation appears fair rather than compelling.
Positive Factors
Improving revenue momentum and strategic-market growth
Renewed volume momentum, particularly in the U.S., Healthcare and Cleanroom businesses, supports a more durable growth profile. These strategic markets can improve mix and customer retention while reducing reliance on weaker or more cyclical demand areas.
Negative Factors
Choppy historical revenue and uneven volume performance
Recent acceleration has not yet established a consistently rising top-line trend. Earlier revenue declines and still-negative full-year volumes suggest demand remains uneven, which could limit operating leverage and make future margin progress less dependable.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving revenue momentum and strategic-market growth
Renewed volume momentum, particularly in the U.S., Healthcare and Cleanroom businesses, supports a more durable growth profile. These strategic markets can improve mix and customer retention while reducing reliance on weaker or more cyclical demand areas.
Read all positive factors
Ansell (ANN) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$5.72B
Dividend Yield1.41%
Average Volume (3M)358.90K
Price to Earnings (P/E)20.1
Beta (1Y)1.14
Revenue Growth1.90%
EPS Growth99.19%
CountryAU
Employees15,000
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)1.46
Shares Outstanding140,313,830
10 Day Avg. Volume341,077
30 Day Avg. Volume358,899
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)1.58
Price to Sales (P/S)1.43
P/FCF Ratio10.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$38.93Price Target Upside-5.87% Downside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)1.61
Revenue Forecast (FY)AU$2.22B
Ansell Business Overview & Revenue Model
Company Description
Ansell Limited is a global enterprise that conceptualizes, innovates, and produces protective equipment for various industries across numerous regions, including Asia Pacific, Europe, the Middle East, Africa, the Americas, and the Caribbean. The c...
How the Company Makes Money
Ansell makes money primarily by selling PPE—most importantly protective gloves—into two broad end markets: (1) healthcare and (2) industrial/specialty industrial. Revenue is generated through product sales to hospitals and healthcare systems, grou...
Ansell Earnings Call Summary
Earnings Call Date:Aug 23, 2026
(Q4-2026)
| Next Earnings Date:Feb 23, 2027
Earnings Call Sentiment Positive
The call presented a clear majority of positive operational and financial outcomes — double-digit EPS growth, higher margins, strong cash conversion, U.S. and Cleanroom-led sales momentum, recurring cost savings (APIP $50M) and improved balance sheet metrics. Management also acknowledged and proactively managed notable headwinds (Middle East cost inflation, U.S. tariffs, commodity volatility, FX hedge losses and non‑cash impairments), and provided a constructive FY'27 EPS guidance range of $1.58–$1.70 with assumptions of continued volume/price momentum and ~$9M FX tailwind. On balance the positives — strong execution, margin expansion, cash generation and concrete operational improvements — outweigh the transient and manageable risks cited.Positive Updates
Top-line growth and second-half momentum
Adjusted net sales grew 5.7% for FY'26 (ex-FX and product exits). Second-half growth accelerated to 9.2%, driven by improving volume trends.
Negative Updates
Middle East crisis cost volatility and ongoing uncertainty
Middle East conflict caused raw material and cost inflation; management passed costs to customers to offset impacts but emphasized continued uncertainty and the need for flexible pricing going forward.
Read all updates
Q4-2026 Updates
Positive
Negative
Top-line growth and second-half momentum
Adjusted net sales grew 5.7% for FY'26 (ex-FX and product exits). Second-half growth accelerated to 9.2%, driven by improving volume trends.
Read all positive updates
Company Guidance
Ansell guided adjusted EPS of $1.58–$1.70 for FY27 (FY26 adjusted EPS $1.486), implying ~6.4%–14.4% upside (midpoint ~$1.64, ≈10.3% growth), on assumptions of continued sales momentum from both volume and pricing, focus on higher‑margin markets/brands and ongoing commercial and operational excellence; management also factored in a $9m FX benefit versus FY25. They expect GPADE and margin improvement from mix and productivity, SG&A to be managed around prior‑year growth (~2.7%), lower net capex than FY26 ($48.6m) with targeted strategic investment, continuation of the on‑market buyback program, and a conservative funding profile (net debt/EBITDA target 1.5–2.5x, currently 1.3x) with $752m of cash and undrawn facilities — while noting macro uncertainty.Ansell Financial Statement Overview
Summary
Income Statement
74
Positive
Balance Sheet
70
Positive
Cash Flow
78
Positive
| Breakdown | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.19B | 2.00B | 1.62B | 1.66B | 1.95B |
| Gross Profit | 906.27M | 825.00M | 624.80M | 616.70M | 625.19M |
| EBITDA | 424.72M | 260.20M | 202.30M | 275.20M | 291.90M |
| Net Income | 213.18M | 101.60M | 76.50M | 148.30M | 158.70M |
Balance Sheet | |||||
| Total Assets | 3.39B | 3.32B | 3.24B | 2.52B | 2.51B |
| Cash, Cash Equivalents and Short-Term Investments | 249.39M | 238.30M | 912.30M | 159.03M | 206.18M |
| Total Debt | 756.27M | 805.60M | 857.20M | 493.15M | 485.74M |
| Total Liabilities | 1.37B | 1.34B | 1.33B | 913.07M | 949.48M |
| Stockholders Equity | 1.99B | 1.96B | 1.89B | 1.60B | 1.54B |
Cash Flow | |||||
| Free Cash Flow | 305.05M | 170.00M | 208.60M | 95.37M | 127.71M |
| Operating Cash Flow | 355.13M | 239.30M | 272.30M | 161.72M | 191.71M |
| Investing Cash Flow | -60.60M | -703.30M | -63.40M | -75.50M | -71.20M |
| Financing Cash Flow | -287.78M | -216.00M | 540.80M | -149.20M | -176.70M |
Ansell Technical Analysis
Positive
41.36
Price Trends
33.52
Positive
30.40
Positive
31.64
Positive
Market Momentum
1.98
Negative
75.13
Negative
71.04
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ANN, the sentiment is Positive. The current price of 41.36 is above the 20-day moving average (MA) of 36.11, above the 50-day MA of 33.52, and above the 200-day MA of 31.64, indicating a bullish trend. The MACD of 1.98 indicates Negative momentum. The RSI at 75.13 is Negative, neither overbought nor oversold. The STOCH value of 71.04 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:ANN.
Ansell Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | AU$48.38B | 23.02 | 23.88% | 1.24% | 4.74% | 4.44% | |
72 Outperform | AU$5.72B | 20.11 | 7.05% | 2.58% | 1.90% | 99.19% | |
65 Neutral | AU$815.50M | 46.35 | 8.16% | ― | 2.59% | -13.36% | |
64 Neutral | AU$51.82M | 82.14 | 1.13% | ― | 8.99% | 450.00% | |
52 Neutral | AU$32.94M | -26.95 | -6.27% | ― | 0.29% | -148.39% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
43 Neutral | AU$25.22M | -41.25 | -0.62% | ― | -3.05% | 86.01% |
* Healthcare Sector Average
AU:ANN
Ansell
40.99
6.78
19.83%
AU:NAN
Nanosonics Limited
2.73
-1.53
-35.92%
AU:MVP
Medical Developments International Limited
0.46
-0.11
-19.30%
AU:TRJ
Trajan Group Holdings Ltd
0.17
-0.76
-82.07%
AU:CSX
CleanSpace Holdings Ltd.
0.42
-0.37
-46.79%
AU:RMD
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
32.74
-8.68
-20.95%
Ansell Corporate Events
Ansell Extends On‑Market Share Buy‑Back Program
Aug 23, 2026
Ansell Limited has announced an extension of its existing on-market buy-back of ordinary fully paid shares, originally notified in December 2025 and previously updated in June 2026. The latest notification confirms the continuation of the capital ...
Ansell Declares USD 0.415 Interim Dividend for June 2026 Period
Aug 23, 2026
Ansell Limited has declared a six‑month dividend on its ordinary fully paid shares, setting a distribution of USD 0.415 per share for the period ended June 30, 2026. The announcement underscores the company’s ongoing commitment to shar...
Ansell Details 2026 Corporate Governance Compliance in ASX Filing
Aug 23, 2026
Ansell has lodged its corporate governance statement for the year ended 30 June 2026 with the ASX and published it on its website, confirming board approval as of 24 August 2026. The statement sets out how the company has applied the ASX Corporate...
Ansell Details FY26 Corporate Governance and ASX Compliance
Aug 23, 2026
Ansell Limited released its FY26 Corporate Governance Statement, highlighting a comprehensive governance framework centred on an experienced board and multiple specialised committees overseeing risk, sustainability, human resources and audit. The ...
Ansell Highlights Use of Non-IFRS Metrics in FY26 Results and Stresses Investor Caution
Aug 23, 2026
Ansell Limited is a global provider of protective solutions, reporting its financial results under International Financial Reporting Standards. The company focuses on safety and protection products across industrial and healthcare settings, target...
Ansell Delivers Strong FY26 Growth as Higher-Value Safety Markets Drive Margins
Aug 23, 2026
Ansell reported strong FY26 performance, with sales rising to $2.14 billion, adjusted EBIT up 14.9% on an organic constant currency basis and adjusted EPS of 148.6 U.S. cents, near the top of guidance. Margin expansion was driven by greater sales ...
United Super exits substantial holder status in Ansell Limited
Aug 18, 2026
Ansell Limited has disclosed that United Super Pty Ltd has ceased to be a substantial shareholder in the company, following changes in its relevant interest in Ansell’s voting securities. The notice, lodged under Australia’s Corporatio...
Ansell Sets Date for FY26 Full-Year Results and Investor Webcast
Jul 12, 2026
Ansell Limited has announced it will release its full-year results for the period ended 30 June 2026 on 24 August 2026, with Managing Director and CEO Nathalie Ahlström and Acting CFO Fred Marx set to host a webcast to discuss the companyR...
Ansell Cancels 466,719 Shares in On-Market Buy-Back
Jul 6, 2026
Ansell Limited has announced the cancellation of 466,719 ordinary fully paid shares on the ASX, executed via an on-market buy-back completed on 1 July 2026. The move modestly reduces the company’s issued capital base and reflects an active c...
Ansell Updates Market on Progress of Ongoing Share Buy‑Back
Jun 30, 2026
Ansell Limited has provided an updated notification to the ASX regarding its ongoing on‑market share buy‑back of ordinary fully paid ANN securities. The announcement confirms the program remains active and outlines the cumulative numbe...
Ansell Cuts Potential Share Dilution as Incentive Securities Lapse
Jun 24, 2026
Ansell Limited has notified the market of the cessation of certain equity-based incentives, including 39,387 restricted stock units and 70,220 performance share rights, after the conditions attached to these awards were not met or became incapable...
Ansell updates market on progress of on‑market share buy‑back
Jun 22, 2026
Ansell Limited has provided an updated notification to the ASX regarding its ongoing on-market share buy-back program, covering ordinary fully paid shares under code ANN. The company reported that it had repurchased a cumulative 3,699,190 shares p...
Ansell Updates Market on Progress of On‑Market Share Buy‑Back
Jun 21, 2026
Ansell Limited has provided an updated notification to the ASX on the progress of its on-market share buy-back program for its ordinary fully paid shares. The latest daily report shows that the company has repurchased a cumulative 3,640,286 shares...
Ansell Names Erik Van den Enden as New Chief Financial Officer
Jun 21, 2026
Ansell Limited has appointed Erik Van den Enden as Chief Financial Officer, effective 1 September 2026, bringing nearly 20 years of international finance leadership experience across consumer goods, telecommunications, and infrastructure. Van den ...
Ansell Issues Daily Update on Ongoing On‑Market Share Buy‑Back
Jun 16, 2026
Ansell Limited has issued an updated notification to the ASX confirming the ongoing execution of its on‑market share buy‑back program for ordinary fully paid shares. The company reported that a total of 3,567,592 shares had been repurc...
Ansell Updates Market on Progress of Ongoing Share Buy-Back
Jun 3, 2026
Ansell Limited has provided an updated notification to the ASX regarding its ongoing on-market share buy-back of ordinary fully paid shares. The latest filing confirms the program remains active and specifies that, as of the day before this notice...
Ansell Updates Investors on Progress of On-Market Share Buy-Back
Jun 1, 2026
Ansell Limited has provided an update on its on-market share buy-back program for its ordinary fully paid shares listed on the ASX. The company reported that it has repurchased a cumulative total of 3,389,602 shares before the previous trading day...
Ansell Advances On‑Market Share Buy‑Back With Daily Repurchases
May 31, 2026
Ansell Limited has continued its on‑market share buy‑back program, reporting that it had repurchased a total of 3,281,691 ordinary fully paid shares before the previous trading day and a further 107,911 shares on the prior day. The lat...
Ansell Updates Market on Progress of Ongoing Share Buy-Back
May 27, 2026
Ansell Limited has provided an updated notification to the ASX confirming the continuation of its on-market share buy-back program for its ordinary fully paid shares. The company reported that a cumulative 3,245,788 shares had been repurchased pri...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.